Matyasovska, N
Valkova, N
Gala, M
Bendikova, S
Abdulhamed, A
Palicka, V.
Renwick, Neil
Čekan, Pavol
Paul, Evan
Funding for this research was provided by:
Ministry of Health of the Slovak Republic (2019/69 MXDX-1, 2019/69 MXDX-1, 2019/69 MXDX-1, 2019/69 MXDX-1, 2019/69 MXDX-1, 2019/69 MXDX-1, 2019/69 MXDX-1, 2019/69 MXDX-1)
Ministry of Health Czech Republic (UHHK, 00179906, UHHK, 00179906)
Charles University, project GA UK (SVV UK, LFHK, No. 260657, SVV UK, LFHK, No. 260657)
program Cooperatio, research area DIAG
Article History
Received: 14 October 2024
Accepted: 31 March 2025
First Online: 11 April 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki. PanNET samples were approved for research purposes through the Queen’s University Health Sciences & Affiliated Teaching Hospitals Research Ethics Board (PATH-145-14) and provided under a Material Transfer Agreement with Ontario Institute for Cancer Research. Non-diseased pancreatic tissues were obtained from the Surgical Pathology Archive in the Department of Pathology and Molecular Medicine at Queen’s University. Samples were approved for research through Research Ethics Board at Queen’s University (PATH-145-14). Written informed consent was obtained from all participants by the Ontario Institute for Cancer Research.
: Consent for publication was obtained from all participants by the Ontario Institute for Cancer Research.
: N.M., N.V., M.G., S.B., P.C., and E.D.P. are employees of MultiplexDX. All other authors declare no competing interests.